Search

everythinglearnresearchcommunity

for

Search:↓

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Switching insulin brands caused skin lesions in a diabetic woman, resolved by changing to oral medication.

CTP-543 is generally safe for treating alopecia areata.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

A protein called sFRP4 from skin cells stops the development of pigment-producing cells in hair.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

4-aminopyridine helps skin wounds heal faster and better.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

The new formulation improves dutasteride's absorption when taken orally.

PPAR activation can improve diabetic wound healing by enhancing blood vessel function.

Finasteride reduced VEGF expression and microvascular density in diabetic mice.